In addition, it seems plausible, based on our findings, that the unfavorable prognosis associated with highly MUC1/HER2-positive breast tumors (data not shown; see [24]) may be attributable to ECM1-mediated upregulation of MUC1. This evidence concerns the gene ERBB2 and breast neoplasm.